Functional and clinical consequences of immune-driven sequence variation of gag-protease in HIV-1 subtypes A, C, D and recombinants.
dc.contributor.advisor | Ndung'u, Peter Thumbi. | |
dc.contributor.advisor | Mann, Jaclyn Kelly. | |
dc.contributor.author | Kiguoya, Marion Wangui. | |
dc.date.accessioned | 2017-06-21T07:59:40Z | |
dc.date.available | 2017-06-21T07:59:40Z | |
dc.date.created | 2016 | |
dc.date.issued | 2016 | |
dc.description | Doctor of Philosophy in Virology. University of KwaZulu-Natal, Medical School 2016. | en_US |
dc.description.abstract | Abstract available in PDF file. | en_US |
dc.identifier.uri | http://hdl.handle.net/10413/14595 | |
dc.language.iso | en_ZA | en_US |
dc.subject | Highly active antiretroviral therapy. | en_US |
dc.subject | HIV infections -- Epidemiology. | en_US |
dc.subject | Immunological tolerance. | en_US |
dc.subject | Recombinant protease inhibitors. | en_US |
dc.subject | Theses -- Virology. | en_US |
dc.title | Functional and clinical consequences of immune-driven sequence variation of gag-protease in HIV-1 subtypes A, C, D and recombinants. | en_US |
dc.type | Thesis | en_US |